FDA.reportPublic FDA data

Cobenfy 125 MG / 30 MG (equivalent to xanomeline tartrate 191.7 MG / trospium 27.5 MG) Oral Capsule

RxCUI
2694855
RxNorm name
Cobenfy 125 MG / 30 MG (equivalent to xanomeline tartrate 191.7 MG / trospium 27.5 MG) Oral Capsule
Display name
Cobenfy 125 MG / 30 MG (equivalent to xanomeline tartrate 191.7 MG / trospium 27.5 MG) Oral Capsule
Full name
Cobenfy 125 MG / 30 MG (equivalent to xanomeline tartrate 191.7 MG / trospium 27.5 MG) Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CobenfyXANOMELINE AND TROSPIUM CHLORIDEE.R. Squibb & Sons, L.L.C.8f0e73bf-6025-44f6-ab64-0983322de0df2026-01-16Warnings, Adverse reactionsExact identifier
rxcui: 2694855

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
8f0e73bf-6025-44f6-ab64-0983322de0dfCOBENFY 125 MG / 30 MG Oral Capsule [PSN] · trospium chloride 30 MG / xanomeline 125 MG Oral Capsule [Cobenfy] [SBD] · Cobenfy (trospium chloride 30 MG / xanomeline 125 MG) Oral Capsule [SY] · Cobenfy 125 MG / 30 MG (equivalent to xanomeline tartrate 191.7 MG / trospium 27.5 MG) Oral Capsule [SY]44These highlights do not include all the information needed to use COBENFY safely and effectively. See full prescribing information for COBENFY. COBENFY™ (xanomeline and trospium chloride) capsules, for oral use Initial U.S. Approval: 202420260116